Onkure Therapeutics, Inc. · NASDAQ:OKUR

ACORN BIOVENTURES, L.P. reported a 13.30% stake in Onkure Therapeutics, Inc. (Schedule 13D/A)

Event May 15, 2025 · Filed May 30, 2025

ACORN BIOVENTURES, L.P. reported a 13.30% stake in Onkure Therapeutics, Inc., 1,709,944 shares, with active intent on May 15, 2025. Filed May 30, 2025 (Schedule 13D/A).

Stake
13.30%
Shares
1,709,944
Intent
Active
What changed
Stake changed
Filed together
5 holders

The filing in full

HolderStakeShares
ACORN BIOVENTURES, L.P.13.30%1,709,944
ACORN CAPITAL ADVISORS GP, LLC13.30%1,709,944
Anders Hove22.10%2,839,674
ACORN BIOVENTURES 2, L.P.8.80%1,129,730
Acorn Capital Advisors GP 2, LLC8.80%1,129,730

Source

View original at SEC

Related